Risk Factors and Multidimensional Assessment of Long Coronavirus Disease Fatigue: A Nested Case-Control Study.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
14 11 2022
Historique:
received: 29 12 2021
pubmed: 12 4 2022
medline: 18 11 2022
entrez: 11 4 2022
Statut: ppublish

Résumé

Fatigue is the most prevalent and debilitating long-COVID (coronavirus disease) symptom; however, risk factors and pathophysiology of this condition remain unknown. We assessed risk factors for long-COVID fatigue and explored its possible pathophysiology. This was a nested case-control study in a COVID recovery clinic. Individuals with (cases) and without (controls) significant fatigue were included. We performed a multidimensional assessment evaluating various parameters, including pulmonary function tests and cardiopulmonary exercise testing, and implemented multivariable logistic regression to assess risk factors for significant long-COVID fatigue. A total of 141 individuals were included. The mean age was 47 (SD: 13) years; 115 (82%) were recovering from mild coronavirus disease 2019 (COVID-19). Mean time for evaluation was 8 months following COVID-19. Sixty-six (47%) individuals were classified with significant long-COVID fatigue. They had a significantly higher number of children, lower proportion of hypothyroidism, higher proportion of sore throat during acute illness, higher proportions of long-COVID symptoms, and of physical limitation in daily activities. Individuals with long-COVID fatigue also had poorer sleep quality and higher degree of depression. They had significantly lower heart rate [153.52 (22.64) vs 163.52 (18.53); P = .038] and oxygen consumption per kilogram [27.69 (7.52) vs 30.71 (7.52); P = .036] at peak exercise. The 2 independent risk factors for fatigue identified in multivariable analysis were peak exercise heart rate (OR: .79 per 10 beats/minute; 95% CI: .65-.96; P = .019) and long-COVID memory impairment (OR: 3.76; 95% CI: 1.57-9.01; P = .003). Long-COVID fatigue may be related to autonomic dysfunction, impaired cognition, and decreased mood. This may suggest a limbic-vagal pathophysiology. NCT04851561.

Sections du résumé

BACKGROUND
Fatigue is the most prevalent and debilitating long-COVID (coronavirus disease) symptom; however, risk factors and pathophysiology of this condition remain unknown. We assessed risk factors for long-COVID fatigue and explored its possible pathophysiology.
METHODS
This was a nested case-control study in a COVID recovery clinic. Individuals with (cases) and without (controls) significant fatigue were included. We performed a multidimensional assessment evaluating various parameters, including pulmonary function tests and cardiopulmonary exercise testing, and implemented multivariable logistic regression to assess risk factors for significant long-COVID fatigue.
RESULTS
A total of 141 individuals were included. The mean age was 47 (SD: 13) years; 115 (82%) were recovering from mild coronavirus disease 2019 (COVID-19). Mean time for evaluation was 8 months following COVID-19. Sixty-six (47%) individuals were classified with significant long-COVID fatigue. They had a significantly higher number of children, lower proportion of hypothyroidism, higher proportion of sore throat during acute illness, higher proportions of long-COVID symptoms, and of physical limitation in daily activities. Individuals with long-COVID fatigue also had poorer sleep quality and higher degree of depression. They had significantly lower heart rate [153.52 (22.64) vs 163.52 (18.53); P = .038] and oxygen consumption per kilogram [27.69 (7.52) vs 30.71 (7.52); P = .036] at peak exercise. The 2 independent risk factors for fatigue identified in multivariable analysis were peak exercise heart rate (OR: .79 per 10 beats/minute; 95% CI: .65-.96; P = .019) and long-COVID memory impairment (OR: 3.76; 95% CI: 1.57-9.01; P = .003).
CONCLUSIONS
Long-COVID fatigue may be related to autonomic dysfunction, impaired cognition, and decreased mood. This may suggest a limbic-vagal pathophysiology.
CLINICAL TRIALS REGISTRATION
NCT04851561.

Identifiants

pubmed: 35403679
pii: 6566295
doi: 10.1093/cid/ciac283
pmc: PMC9383780
doi:

Banques de données

ClinicalTrials.gov
['NCT04851561']

Types de publication

Clinical Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1688-1697

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Déclaration de conflit d'intérêts

Potential conflicts of interest. The authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest.

Auteurs

Ili Margalit (I)

Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
COVID Recovery Clinic, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel.

Dana Yelin (D)

COVID Recovery Clinic, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel.

Moshe Sagi (M)

Department of Internal Medicine F, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.

Maya Merav Rahat (MM)

Department of Internal Medicine E, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.

Liron Sheena (L)

Department of Internal Medicine F, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.

Nadav Mizrahi (N)

Department of Internal Medicine B, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.

Yael Gordin (Y)

The Hebrew University-Hadassah Medical School, Hebrew University, Jerusalem, Israel.

Hadar Agmon (H)

Department of Internal Medicine B, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.

Nitzan Karny Epstein (NK)

Department of Internal Medicine B, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.

Alaa Atamna (A)

Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
COVID Recovery Clinic, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel.

Ori Tishler (O)

COVID Recovery Clinic, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
Department of Internal Medicine F, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.

Vered Daitch (V)

Department of Internal Medicine E, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.

Tanya Babich (T)

Research Authority, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.

Donna Abecasis (D)

Functional MRI Center, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.

Yoni Yarom (Y)

Medix Sport Medicine Center, Tel Aviv, Israel.

Shirit Kazum (S)

Department of Cardiology, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.

Dorit Shitenberg (D)

Pulmonary Institute, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.

Erik Baltaxe (E)

Pulmonary Institute, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.

Odelia Elkana (O)

Behavioral Sciences, Academic College of Tel Aviv-Yafo, Tel Aviv-Jaffa, Israel.

Irit Shapira-Lichter (I)

Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel.
Functional MRI Center, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
Sagol School of Neuroscience, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel.

Leonard Leibovici (L)

Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel.
Research Authority, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.

Dafna Yahav (D)

Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
COVID Recovery Clinic, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH